People living with HIV are aging, often with the same mobility, cognitive and chronic-care needs as other older adults. The decisive issue is rarely whether a home has an “HIV bed.” It is whether the provider can maintain antiretroviral therapy without interruption, coordinate specialist and pharmacy care, use routine infection precautions and protect the resident from unnecessary disclosure or stigma. These are testable admission questions.
organize a meaningful medication review in long-term care; identify the clinician responsible inside the home; compare Canadian care homes by location and services.
Make treatment continuity the first admission test
Ask who will prescribe antiretroviral therapy, which pharmacy supplies it and how the first doses will be available on move-in day. Bring a reconciled medication list, dosing schedule, allergies and recent specialist contact with consent. A missed handoff can interrupt treatment even when everyone assumes someone else ordered it. Clarify after-hours access if a dose is missing or vomiting prevents administration.
Review interactions without destabilizing a working regimen
Long-term care often adds pain, sleep, cardiovascular and psychiatric medicines. The prescriber and pharmacist should review interactions with antiretroviral therapy and other drugs, including non-prescription products. Families should not stop, crush or retime medication on their own. Ask how the home handles medicines that require particular storage, administration or swallowing arrangements, and how changes are communicated to the HIV specialist.
Build a compact clinical handover
The receiving team needs enough information to act, not an uncontrolled copy of every past record. With the resident’s authorization, assemble current ART, relevant laboratory monitoring, comorbidities, vaccination history, pharmacy details and the specialist follow-up plan. Note how the resident communicates symptoms and whether they self-manage any medication. Assign a date for the first medication and medical review.
- Exact antiretroviral names, doses and administration times
- Prescriber, HIV clinic and dispensing pharmacy contacts
- Monitoring due dates and transport or virtual-care plan
- Known interactions, allergies and swallowing needs
- Consent instructions for sharing HIV-related information
Expect routine precautions, not social isolation
HIV is a chronic treatable condition and ordinary social contact does not transmit it. Staff should use standard infection-prevention practices based on the task and exposure risk, as they do for all residents. Separate dishes, exclusion from activities or a warning label on the bedroom door are not appropriate responses to HIV status. Ask how the home trains staff and addresses discriminatory behaviour.
Limit disclosure to people who need the information
The resident’s diagnosis is personal health information. Discuss who needs it for treatment and what the resident wants relatives, roommates or visitors to know. Avoid placing HIV status on general activity lists or informal handover sheets. Where a substitute decision-maker is involved, clarify the scope of their authority. Privacy does not prevent necessary clinical communication; it requires purposeful, secure sharing.
Plan specialist access and common aging needs together
Good HIV care cannot be isolated from falls, cognition, kidney function, bone health, nutrition and mental wellbeing. Ask whether appointments require an escort, who books laboratory tests and how recommendations enter the care plan. A home that can coordinate chronic disease reliably may be a better fit than one that advertises expertise but cannot explain handoffs, transport or urgent escalation.
Use a first-week continuity checklist
On the day of admission, verify that every antiretroviral dose is physically available, entered correctly on the medication record and scheduled as prescribed. Confirm whether any tablet may be crushed before changing its form. Match the resident’s own supply with pharmacy orders to prevent both a gap and double dosing. Record whom staff call if the medication is delayed.
Within the first week, confirm the responsible physician or nurse practitioner has reviewed the transfer information and that the HIV clinic knows the new address and contact route. Book any due laboratory work and decide whether follow-up will be in person, virtual or shared with primary care. Ask how results reach the prescriber and who acts on an abnormal finding; “the clinic will see it” is not a closed loop.
Finally, ask the resident privately how disclosure and staff behaviour have felt. Medication continuity can look perfect while dignity is being damaged by whispers, gloves used for casual contact or exclusion. Correct small problems early. Schedule another review after any hospital stay, pharmacy change or major new prescription, because these transitions are the points at which a stable regimen is most likely to be disrupted.
Include contingency stock and hospital-transfer instructions in the conversation without hoarding medication. Ask the pharmacy and prescriber what happens during a delivery disruption, evacuation or temporary hospital stay, and who reconciles ART on return. The answer should use the home’s normal emergency system while recognizing that substitutions or interruptions require expert advice. A written contact route is safer than expecting an unfamiliar emergency clinician to reconstruct a complex regimen from family memory. Test that route once and keep the confirmed details with the transfer papers. Add the last confirmed medication list and clinic callback number whenever the transfer envelope is renewed.
Must we disclose HIV during the first enquiry?
A family can initially ask capability questions without broadcasting a diagnosis to multiple homes. Before admission, relevant clinical information must reach the professionals assessing safe care, with lawful authority and consent. Ask how sensitive records are received and who sees them. Do not omit information in a way that creates medication or care risk; use a controlled clinical channel instead of a public form or casual email.
What if staff appear afraid or use stigmatizing language?
Correct misinformation calmly, document the incident and raise it with the clinical lead or administrator. Ask for immediate protection from discriminatory treatment and a concrete education response. Serious or unresolved concerns can move through the provider’s complaint route, provincial regulator, privacy office or human-rights process as appropriate. The resident should not have to educate every worker personally.
What must be verified before admission?
Confirm medication supply, responsible prescriber, pharmacy capability, specialist follow-up, transport, privacy handling and current clinical suitability directly with the home and health team. Provincial coverage and local services vary. The provider must assess the individual case and confirm admission; this guide cannot determine medical fitness, drug interactions, funding or bed availability.